Schreiner MediPharm unveils film for drug trials

Schreiner MediPharm, a Germany-based converter of specialty pharmaceutical labels, has introduced a translucent, self-adhesive film to neutralize color differences between placebo and drug products used in clinical trials.  

Before being approved, every drug must successfully pass the test of clinical trials. In many of these trials, investigators and subjects are not permitted to know whether an effective drug or a placebo is being administered. Often, trials involve liquid substances that obviously differ in color and such visual differences must be reliably neutralized. However, the person dispensing the substance must still be able to see how much liquid is contained in the vial or syringe.  

The disguises any differences in color, while preserving the view of the fill level. ‘We are very excited to bring this product to market,’ said Gene Dul, president of Schreiner MediPharm. ‘It is a unique, effective product that we believe will play a major role in clinical trials.’ 

Schreiner MediPharm’s new film can be adapted to suit the color of the liquids. In addition, it can be printed with graduation lines and product information, and a “proof-of-first-opening” element can be integrated as well. 

Pictured (l-r): Before and after neutralization

Click here for more stories about Schreiner MediPharm on L&L.com.